1. Scrip
  2. >>Business
  3. >>Strategy

Will Radiopharmaceutical Company AAA Be M&A Fodder For Novartis?

 
• By Lucie Ellis-Taitt

Novartis, which is focused on securing bolt-on acquisitions rather than mega-M&A to bolster its pipeline, might have found the right target in French radiopharmaceutical company Advanced Accelerator Applications – if rumors are to be believed.

Business teamwork puzzle pieces.
Is french firm AAA a missing piece in the Novartis puzzle?

Summer is over, the pharma sector is back from vacation and the M&A rumor mill is churning once again. This time its Novartis AG provoking the chatter, as the big pharma is supposedly looking to acquire radiopharmaceutical company Advanced Accelerator Applications SA.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

Deal Watch: Lilly Looks To Creyon For Oligonucleotides

 
• By Joseph Haas

Plus deals involving J&J/Addex/Sinntaxis, Concentra/Kronos, Granata/Oviva, Coeptis/Z Squared, Ligand/Channel and more.

Accelerated Approval May Be Out Of Reach For PTC’s Huntington’s Drug

 
• By Joseph Haas

PTC said its updated Phase II data for PTC 518 met the primary endpoint of Huntingtin’s protein reduction, but analysts said there isn’t clear correlation with clinical benefit.

AstraZeneca COPD Drug Breztri Breezes Through Asthma Trials

 
• By Kevin Grogan

The triple therapy improves lung function in the Phase III KALOS and LOGOS studies

Biogen’s Manufacturing Sites, Revenue Sources Protect It From Big Tariff Impact

 
• By Mandy Jackson

Biogen expects little impact from existing tariffs and any that may apply if the US exemption of pharma products is lifted, since 75% of its manufacturing is in the US and 55% of sales are ex-US.

More from Business